CD1 activators comprise a unique class of chemical compounds specifically designed to elevate or enhance the activity or expression of CD1 proteins. These glycoproteins, primarily displayed on the surface of specific antigen-presenting cells, are instrumental in lipid antigen presentation. By understanding and modulating their activity, researchers gain crucial insights into certain lipid-mediated immune responses.
Direct activators within this class are tailored to have an affinity for the CD1 protein. Their mode of action is centered around forming a direct interaction, typically a binding event, with the CD1 protein. This binding event could stabilize the protein, potentiate its intrinsic function, or trigger a cascade of events amplifying its activity within the cell. The molecular architecture of these activators is carefully crafted to ensure optimal engagement with CD1, emphasizing specificity and the resulting amplification of function. In contrast, indirect activators, while not interacting with the CD1 protein directly, induce conditions or cellular responses that culminate in an upregulation of CD1 activity or expression. This might involve stimulating pathways leading to increased transcription of the CD1 genes, modulating protein stability mechanisms, or influencing other cellular components that indirectly boost CD1 function.
Items 11 to 12 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $66.00 $278.00 | 6 | |
An immune response modifier which might indirectly modulate CD1 function. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Known to have various cellular effects, including modulation of immune responses. |